New to Meducation?
Sign up
Already signed up? Log In
view moderators

MultipleSclerosis

Category

Preview
0
0

New EMA Advice for PML Prevention With Tysabri in MS

The European Medicines Agency has released new recommendations on PML prevention with natalizumab in multiple sclerosis.  
medscape.com
over 4 years ago
Preview
0
0

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016: Read clinically focused news coverage of key developments from ACTRIMS 2016.  
medscape.com
over 4 years ago
Preview
0
1

Multiple Sclerosis Leadership Summit: Scientific Advances and Clinical Updates in MS Treatment & Care CME

This activity has been designed to meet the educational needs of neurologists and other physicians specializing in the treatment of MS patients, as well as nurse practitioners practicing in MS comprehensive care centers, free standing MS centers, private and group practices, MS academic and research programs, rehabilitation centers, VA MS COE programs, and long-term care facilities.  
medscape.org
over 4 years ago
Preview
0
0

INFORMS Published: Fingolimod Fails in Primary Progressive MS

Full details of the INFORMS trial have confirmed that the multiple sclerosis drug fingolimod did not slow progression of disability or brain volume loss vs placebo in the primary progressive form of the disease.  
medscape.com
over 4 years ago
Preview
0
8

Biomarkers May Predict Progression in MS

Researchers have identified a proinflammatory profile in CSF that may correlate with cortical pathology and could prove useful to stratify patients with early progressive multiple sclerosis.  
medscape.com
over 4 years ago
Preview
0
0

Stem Cell Transplant in Multiple Sclerosis: Next Steps

Hematopoietic stem cell transplant looks promising in relapsing MS, while more biologically cell-based approaches may be needed for progressive forms. Two important studies are in development.  
medscape.com
over 4 years ago
Preview
0
0

High Daily Coffee Consumption Linked to Lower MS Risk

Drinking more than six cups of coffee per day was linked to a reduced risk of developing multiple sclerosis in two new case-control studies.  
medscape.com
over 4 years ago
Preview
0
0

Low Vitamin D in Pregnancy Linked to Higher MS in Offspring

New research raises the possibility that correction of vitamin D deficiency during pregnancy may reduce the risk for multiple sclerosis in the next generation.  
medscape.com
over 4 years ago
Preview
0
1

Environment may play significant role in multiple sclerosis

Environmental factors may play a far greater role in the onset of multiple sclerosis (MS) than previously thought, shows a study that compared rates of the condition in immigrants to east London with those of their ancestral groups.  
feeds.bmj.com
over 4 years ago
Preview
0
0

Multiple Sclerosis: Comorbidities Common at Diagnosis

A new study raises the question of whether there are shared risk factors for MS and other chronic medical conditions.  
medscape.com
over 4 years ago
Preview
0
0

Diabetes Drugs Have Positive Effect in MS

Metformin and pioglitazone help regulate immune and inflammatory responses in obese patients with multiple sclerosis who also have metabolic syndrome, a new study suggests.  
medscape.com
over 4 years ago
Preview
0
0

What's on the Horizon in MS: A Review of Novel Therapies and Emerging Approaches CME

The goal of this activity is to provide information about upcoming clinical trial data and emerging therapies for multiple sclerosis (MS).  
medscape.org
over 4 years ago
Preview
0
0

Neurology Exchange: Individualizing Therapy and Optimizing Treatments in MS CME

The target audience for this educational initiative includes neurologists, multiple sclerosis (MS) specialists, primary care physicians, and other healthcare professionals who manage patients with MS.  
medscape.org
over 4 years ago
Preview
0
0

Neurology Exchange: Integrating New DMD Therapies Into the MS Treatment Landscape CME

The target audience for this educational initiative includes multiple sclerosis (MS) specialists, neurologists, primary care providers (PCPs), and other healthcare professionals who manage patients with MS.  
medscape.org
over 4 years ago
Preview
0
0

Fingolimod Easier to Swallow Than Dimethyl Fumarate?

Patients with multiple sclerosis are more likely to discontinue dimethyl fumarate than fingolimod after 2 years or less, largely because of tolerability issues, a real-world study has found.  
medscape.com
over 4 years ago
Preview
0
0

Predictors of Nonadherence in Multiple Sclerosis

From the AAN Annual Meeting, Medscape speaks with doctoral candidate Kyla McKay about predicting treatment nonadherence in patients with multiple sclerosis.  
medscape.com
over 4 years ago
Preview
0
0

Health anxiety: the silent, disabling epidemic

“We are glad to say, Mr Jones, that all your test results are normal and you have nothing to fear.” Mr Jones has received this message many times after being examined for many severe diseases such as cancer, multiple sclerosis, and heart disease, which over the years he has been convinced he must have. Yet, this is the core of his problem—despite how much he would like to, he cannot do what the doctor says: stop worrying. He used to attend his general practitioner frequently to be reassured that nothing was wrong with him, but the reassurance was only short lived and then the worrying started all over again. After many years of distress, Mr Jones is embarrassed that he cannot control his health worries and preoccupation and has lately avoided contact with his GP, knowing it does not help him very much.  
feeds.bmj.com
over 4 years ago
Preview
0
0

Health anxiety: the silent, disabling epidemic

“We are glad to say, Mr Jones, that all your test results are normal and you have nothing to fear.” Mr Jones has received this message many times after being examined for many severe diseases such as cancer, multiple sclerosis, and heart disease, which over the years he has been convinced he must have. Yet, this is the core of his problem—despite how much he would like to, he cannot do what the doctor says: stop worrying. He used to attend his general practitioner frequently to be reassured that nothing was wrong with him, but the reassurance was only short lived and then the worrying started all over again. After many years of distress, Mr Jones is embarrassed that he cannot control his health worries and preoccupation and has lately avoided contact with his GP, knowing it does not help him very much.  
feeds.bmj.com
over 4 years ago
Preview
0
0

Health anxiety: the silent, disabling epidemic

“We are glad to say, Mr Jones, that all your test results are normal and you have nothing to fear.” Mr Jones has received this message many times after being examined for many severe diseases such as cancer, multiple sclerosis, and heart disease, which over the years he has been convinced he must have. Yet, this is the core of his problem—despite how much he would like to, he cannot do what the doctor says: stop worrying. He used to attend his general practitioner frequently to be reassured that nothing was wrong with him, but the reassurance was only short lived and then the worrying started all over again. After many years of distress, Mr Jones is embarrassed that he cannot control his health worries and preoccupation and has lately avoided contact with his GP, knowing it does not help him very much.  
feeds.bmj.com
over 4 years ago